Ebola vaccine developed in Canada shows promising results
A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants 6 months after immunization. ...
Jun 19, 2017
0
105
